Originalartikel 2022

  • Schymik HS, Dahlem C, Barghash A, Kiemer AK. 2022. Comment on: The m6A reader IGF2BP2 regulates macrophage phenotypic activation and inflammatory diseases by stabilizing TSC1 and PPARγ. Advanced Sci 2104372
     
  • Dahlem C, Abuhaliema A, Kessler SM, Kröhler T, Zoller BGE, Chanda S, Wu Y, Both S, Müller F, Lepikhov K, Kirsch SH, Laggai S, Müller R, Empting M, Kiemer AK. 2022. The first small molecule inhibitors targeting the RNA binding protein IGF2BP2/IMP2 for cancer therapy. ACS Chem Biol 17:361-375
     
  • Köhler N, Höring M, Czepukojc B, Rose TD, Buechler C, Kröhler T, Hayback J, Liebisch G, Pauling J, Kessler SM, Kiemer AK. 2022. Kupffer cells are protective in alcoholic steatosis. Biochim Biophys Acta Mol Basis Dis 1868:166398 
     
  • Dahlem C, Chanda S, Hemmer J, Schymik HS, Kohlstedt M, Wittmann C, Kiemer AK. 2022. Characterization of anti-cancer activities of violacein: Actions on tumor cells and the tumor microenvironment. Front Oncol 12:872223 )
     
  • Huck BC, Thiyagarajan D, Bali A, Boese A, Besecke KFW, Hozsa C, Gieseler RK, Furch M, Carvalho-Wodarz C, Waldow FSchwudke D, Metelkrina O, Titz A, Huwer H, Schwarzkopf K, Hoppstädter J, Kiemer AK, Koch M, Loretz B, Lehr CM. 2022. Nano-in-microparticles for aerosol delivery of antibiotic-loaded, fucose-derivatized and macrophage-targeted liposomes to combat mycobacterial infections: in vitro deposition, pulmonary barrier interactions, and targeted delivery. Adv Healthc Mater 2102117
     
  • Park YM, Dahlem C, Meyer MR, Kiemer AK, Müller R, Herrmann J. 2022. Induction of liver size reduction in zebrafish larvae by the emerging synthetic cannabinoid 4F-MDMB-BINACA and its impact on drug metabolism. Molecules 27:1290
     
  • Mehanny M, Boese A, Bornamehr B, Hoppstädter J, Presser V, Kiemer AK, Lehr CM, Fuhrmann G. 2022. Spray-dried pneumococcal membrane vesicles are promising candidates for pulmonary immunization. Int J Pharm doi:10.1016/j.ijpharm.2022.121794